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Available online 19 September 2011AbstractAim: A lack of consistency in the definition of breast cancer related lymphoedema (BCRL) and of uniform measurement criteria contribute
to the wide prevalence range found in current literature. This report aims to describe the long-term prevalence of BCRL and secondly, to
compare the long-term prevalence of BCRL when assessed by two objective measures and one subjective measure.
Methods: The upper-limbs of 145 post-surgical breast cancer patients were evaluated for the presence of lymphoedema using the water
displacement method. Two circumference methods and patient perceived swelling were applied secondarily for comparison. Limb measure-
ments were performed once, more than five years after surgery.
Results: The long-term prevalence of BCRL using water displacement was 8%. Prevalence varied when the sum of arm circumference
(SOAC), the arm circumference and the self-report methods were used: 16, 31 and 17% [P < 0.001], respectively. Of the women identified
with BCRL using the water displacement technique, 82% were detected with the SOAC method, 82% with the arm circumference method
and 91% by self-report. Using water displacement as the gold standard the methods with the highest specificities were the SOAC (90%) and
self-report method (89%), arm circumference resulted in a low specificity of 73%.
Conclusion: The prevalence of BCRL more than five years after surgical treatment differs depending on the measuring method used. Our
data underlines the necessity for consensus on the diagnostic criteria for BCRL.
 2011 Elsevier Ltd.
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Early breast cancer detection and concomitant advance-
ments in treatment options have not only resulted in an in-
crease in breast cancer survival rates, but also in that of
disease related morbidities with upper-limb lymphoedema
being one of the most debilitating. Swelling of the oedem-
atous limb is brought on by obstruction of normal lymph
flow, with known treatment risk factors which cause dam-
age to the lymph vessels being axillary dissection, mastec-
tomy and adjuvant radiation therapy.1e7 Breast cancer
related lymphoedema (BCRL) could present with pain,
loss of sensibility, strength and mobility of the affectedAbbreviations: BCRL, breast cancer related lymphoedema; SOAC,
sum of arm circumference; BIS, bioelectrical impedance spectroscopy.
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logical impairments.8e12 Lack of consistency in the defini-
tion of BCRL and a lack of uniform measurement criteria
have contributed to the wide prevalence range found in cur-
rent literature.1e4 This is illustrated in a review on the late
morbidity after treatment of breast cancer, in which the
prevalence was reported to range between 6 and 43%.5
Moreover, few studies have described the long-term preva-
lence of BCRL13e16 and none, to our knowledge, have done
so with the use of different measuring methods within the
same patient group.
Therefore, the current study was conducted primarily
with the aim of assessing the long-term prevalence of
BCRL in women more than five years after breast cancer
treatment. We also sought to assess the source of variation
in BCRL prevalence by comparing prevalence outcomes of
four different measuring methods (water displacement
method, two arm circumference methods and self-
reported limb swelling).
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sity Medical Centre (MUMCþ) between January 2001 and
December 2003 was queried to identify women operated
for breast cancer five or more years prior to search
(n ¼ 386). Exclusion criteria were death (n ¼ 96), migra-
tion (n ¼ 8) and loco-regional recurrence (n ¼ 34). 248 el-
igible women were asked to take part in our study. 93
patients withheld written consent and ten patients ulti-
mately did not take part due to personal circumstances or
illness, resulting in a study population of 145 women.
The hospital’s medical ethics committee approved the study
and the consent form.Lymphoedema measurementsFour methods were used to assess the long-term preva-
lence of BCRL: the water displacement method, two arm
circumference methods and the self-report method. The wa-
ter displacement method was regarded as the gold standard.
In order to evaluate the type of measurement as a probable
source of variance, we compared the prevalence of the two
circumference methods and the self-report method with the
gold standard. All limb measurements were performed at
one moment in time, five or more years after breast cancer
surgery. For each method the breast cancer treated side was
compared to the untreated side. One researcher (JS) per-
formed all limb measurements.
Water displacement method
For the assessment of upper-limb volume a home built
volumeter was used according to J. Lette.17 This method car-
ries a high reproducibility.18 A line was drawn at 80% of the
arm length, measured from the tip of the third digit to the tip
of the acromion. Subjects were instructed to lower the arm
straight and slowly into the volumeter and to stop and keep
it still when the 80%-line reached the water surface. Both
upper-limbs were measured twice. The overflowing water
was collected in a bucket and weighed on a calibrated scale.
(PR balance, Mettler-Toledo, Switzerland). The conversion
value of 1 kg¼ 1000mLwas applied. Lymphoedemawas de-
fined as a limb volume difference greater than 200 mL be-
tween the treated and untreated side.
Circumference method
The arm circumference was measured at ten sites on
both limbs using a tape measure. The locations measured
were: mid-metacarpal, the wrist and at 20, 15, 10 and
5 cm below and above the elbow fold. The sum of these cir-
cumferences was calculated per limb. Lymphoedema was
defined as a difference of the sum of arm circumferences
(SOAC) of more than 5 cm between the treated and un-
treated side or as a difference of arm circumference ofmore than 2 cm between the treated and untreated side at
any of the 10 measured locations on the limb.19
Self-reported lymphoedema
Patients were asked to indicate the presence of (refrac-
tory) swelling during a standardized interview by answer-
ing the following question with a “yes” or “no”: Have
you experienced swelling of the upper-limb on the breast
cancer treated side in the past year? Self-assessment was
described as negative or positive for BCRL.Statistical analysisPatient and clinical characteristics were described using
descriptive statistics. Continuous variables were evaluated
for normal distribution and expressed by providing the me-
dian and range. c2 was used to test the relationship between
categorical variables. A P-value <0.05 was considered sta-
tistically significant. The sensitivity and specificity were
measured for the SOAC, the circumference and the self-
report methods, using the water displacement method as
a reference. All data-analysis was conducted using SPSS
for Windows 17.0 (SPSS Inc. Chicago, Illinois).
ResultsPatient characteristicsThe 145 women included in this study were evaluated
for BCRL after a median period [range] of 6.2 years since
time of surgery [5.0e7.8]. At time of surgery, subjects’ age
ranged from 33 to 86 years with a median of 55.0 years.
The median [range] body mass index (BMI), calculated us-
ing the patients weight and height at time of surgery, was
25.1 [17.1e48.9]; a total of 28 patients were considered
obese (BMI  30) at that time. The majority (n ¼ 123)
of the women underwent breast-conserving surgery; 22
women underwent ablative breast surgery. Of all patients,
69 had an axillary lymph node dissection (ALND) and 76
had a sentinel lymph node biopsy (SLNB). Radiation treat-
ment either to the breast or chest wall and supraclavicular
was given to 125 women.Lymphoedema measurementsUsing the gold standard, 11/145 women met the criteria
of the water displacement method for the diagnosis of lym-
phoedema. When patients were evaluated for lymphoedema
using the SOAC, the circumference and patient self-report
methods, prevalence differed: 23/145, 45/145 and 25/145,
respectively. The difference between the four prevalence
rates was significant [P < 0.001]. Of the 28 obese women
at baseline, 18 developed lymphoedema according to at
least one of the four measuring methods [P ¼ 0.008]. As
for the 69 women who underwent ALND, almost half
(n ¼ 37) had either self-reported lymphoedema and/or
Table 2
Patient perception and measured breast cancer related lymphoedema. Pa-
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sulted in fewer patients with lymphoedema [P ¼ 0.007].tients are divided into categories combining objective (measured) lym-
phoedema prevalence using the water displacement (gold standard), the
SOAC or the arm circumference method with perceived swelling. (Abbre-
viations: BCRL ¼ breast cancer related lymphoedema, SOAC ¼ sum of
Sensitivity and specificity of lymphoedema
measurementsarm circumference).




No BCRL (%) 82 76 63
Asymptomatic BCRL (%) 1 6 20
Symptomatic non-BCRL (%) 10 8 6
Symptomatic BCRL (%) 7 10 11Table 1 presents the sensitivity and specificity of the
SOAC, the circumference and self-report methods using
the water displacement method as reference measure. The
self-report method displayed the highest sensitivity of the
three. Comparatively, the circumference and the SOAC
methods each identified fewer women presenting with lym-
phoedema according to the water displacement method.
The highest specificity was however measured by the
SOAC method. Moreover, there were several cases in
which patients had measured lymphoedema according to
criteria of the SOAC (n ¼ 14) or the circumference method
(n ¼ 36) without having a difference in limb volume greater
then 200 mL and vice versa (n ¼ 3).Patient perception and measured lymphoedemaWe were also interested in the prevalence of women with
subjective lymphoedema. In order to get a wider scope on
the problem at hand, we combined self-reported complaints
of swelling with objective (measured) swelling. Table 2
presents patients categorized as follows: no BCRL (no sub-
jective complaints and no measured swelling), asymptom-
atic BCRL (no subjective complaints but measured
swelling), symptomatic non-BCRL (subjective complaints
but no measured swelling) and symptomatic BCRL (sub-
jective complaints and measured swelling). Once again,
the prevalence rates varied depending on the diagnostic
method used. Interestingly, there were women with the per-
ception of arm swelling but without clinical signs of lym-
phoedema according to all three methods. However, there
were also women with clinical signs of lymphoedema
who did not have self-perceived arm swelling.
DiscussionLong-term prevalenceIn the current studywe assessed the prevalence ofBCRLat
a median time of 6.2 years after breast cancer surgery. To ourTable 1
Sensitivity and Specificity. The sensitivity and specificity of the different
methods are calculated using the water displacement method as reference
measure, 95% confidence interval included. (Abbreviations: SOAC ¼ sum
of arm circumference, CI ¼ confidence interval).
Measurement methods Sensitivity Specificity
% 95% CI % 95% CI
Circumference 82 0.48e0.97 73 0.65e0.80
SOAC 82 0.48e0.97 90 0.83e0.94
Self-report 91 0.57e0.99 89 0.82e0.93knowledge this is the first study that used more than onemea-
suring method for describing the long-term prevalence of
BCRL. Awide point prevalence range of 8e31% was found
in our data, with the circumference method at prevalence
rate of 31%being thebiggest outlier. In contrast, thewater dis-
placement, the SOAC and self-report methods yielded point
prevalence estimates closer in range, 8e17%. Of the scant
long-term data that is available, Sagen et al. reported
aBCRLprevalence of 13%measuredwith thewater displace-
ment method five years after breast cancer treatment.20Lymphoedema: more than just limb swelling?Lymphoedema constitutes more than just limb volume
increase; symptoms that patients experience as result of
that volume change should therefore also be identified. Cre-
ating BCRL sub-categories, depicting subjective com-
plaints against the different objective measurements,
resulted in a better insight on this topic.21,22 Symptomatic
BCRL was identified in 7% of the patients using the water
displacement method; this was 10% for the arm circumfer-
ence method and also 10% for the SOAC method. At a fol-
low-up time of five years after breast cancer treatment
McLaughlin et al reported a prevalence of 5% for symp-
tomatic BCRL measured with the circumference method.14
We assessed a point prevalence double that after a median
time of 6.2 years, which is likely explained by the fact that
our cohort included more women who underwent axillary
lymph node dissection (47 vs. 36%).
Not all patients with self-reported complaints of BCRL
had clinical measurable signs of limb swelling (symptomatic
non-BCRL). The discordance seen between patient percep-
tions and measured swelling is consistent with the results re-
ported in other studies.14,23 A reason why not all of the
subjective BCRL complaints might have shown a measured
increase of limb volume or circumference could be due to
the timing of the study. Many patients reported to have an in-
crease in complaints after more than average exercise and
with warm weather. The measurements in this study gave
an impression of a patient’s lymphoedema status at one spe-
cific moment in time, and thus, cannot exclude the existence
of refractory limb swelling. Furthermore, symptomatic non-
1062 T.R. Lopez Penha et al. / EJSO 37 (2011) 1059e1063BCRL could also be explained by sensory changes in the
treated limb due to neurological damage caused by axillary
surgery or radiation treatment. Vice versa, some women
with measurable volume and or circumference difference
had no subjective complaints of pain or swelling (asymptom-
atic BCRL). An important question is whether this BCRL
category is clinically relevant; in other words if these patients
will eventually go on to develop symptomatic BCRL.Method selection: a matter for considerationVolumetry is the most reliable method for the assessment
of lymphoedema, with the classic water and the novel opto-
electronic (perometer) volumeter forming the two methods
of choice. Both methods have comparable reliability24e27;
therefore, our selection of the water displacement method
was based on cost-efficiency, the most applied method and
readily available device. Even though we have used thewater
displacement method as our gold standard, we believe it to
have its shortcomings in cases where minor swelling is ac-
companied by muscle atrophy. This can develop over time
when normal use of the affected limb is avoided due to lym-
phoedema related symptoms, such as pain and heaviness.Mi-
nor volume increase in the form of extracellular lymph
accumulation can be compensated by a volume decrease in
musclemass, inwhich case lymphoedemawill go undetected.
Bioelectrical impedance spectroscopy (BIS) on the other
hand can accurately differentiate extracellular fluid from
other tissues and thus solely assess lymph volume bymeasur-
ing the impedanceof a spectrumof low frequency electric cur-
rent passed through a body region.28e30 It could therefore be
argued as to why BIS was not used in the current study as the
gold standard for BCRL assessment instead of the water dis-
placement method. Hayes et al described the short-term prev-
alence at six months after breast cancer treatment using the
BIS method as the gold standard and the sum of arm circum-
ference and the patient self-report method for comparison.31
Importantly, in the early stages of lymphoedema swelling is
refractory and predominately constitutes of extracellular
lymph fluid, thereby making BIS a suitable tool for diag-
nosis.32e35 However, as disease progression ensues, limb
swelling becomes a more permanent entity with the occur-
rence of fibrosis and fat deposition.36 As the aim of our study
was to assess the long-term prevalence of BCRL five or more
years after breast cancer treatment, some lymphoedema cases
might have already progressed into the chronic phase during
this period. Thus, the use of BIS instead of thewater displace-
ment method as the gold standard for the identification of
BCRL in this study’s setting is not justified. For lack of
a more reliable assessmentmethodwe have accepted the pos-
sible limitations of the water displacement method.Study limitationAweakness of this study is the fact that it was performed
without pre-operative or direct postoperative baselinemeasurements; these could have produced a more accurate
identification of changes in limb volume and circumfer-
ence. Instead, the contra-lateral upper-extremity was used
as comparison to determine the presence of lymphoedema.
Differences in circumference or arm volume may exist be-
tween a woman’s dominant and non-dominant arm. In most
women these differences are less than 2 cm and therefore
not significant.6,7 However, slight pre-operative limb vol-
ume or circumference differences might mask the presence
of minor lymphoedema in the smaller extremity.
Conclusions
The prevalence of BCRL more than five years after
surgical treatment differs depending on the measuring
method used. The range of prevalence rates observed in
this one group of women measured at a single point in
time by four different methods, underlines the necessity
for consensus on the diagnostic criteria for BCRL. Cur-
rently, there is no single measuring method that can iden-
tify lymphoedema error-free, this is in part due to the
changing nature of lymphoedema. We advice screening
breast cancer patients by using a combination of subjec-
tive complaints and pre-operative and sequential postoper-
ative limb volume measurements (water displacement
method), eliminating the chance of missing minor cases
of limb swelling. This approach will result in more knowl-
edge on the true prevalence of BCRL. Furthermore, the
efficacy of therapeutic regimens and the design of optimal
therapeutic approaches can be assessed creating the begin-
ning of an accepted evidence based systemic approach of
the problem of BCRL. Finally, the implementation of
a lymphoedema screening program will clarify the clinical
relevance of the asymptomatic BCRL and symptomatic
non-BCRL categories.Conflict of interest statement
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